These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8630916)

  • 1. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.
    Sastre-Garau X; Jouve M; Asselain B; Vincent-Salomon A; Beuzeboc P; Dorval T; Durand JC; Fourquet A; Pouillart P
    Cancer; 1996 Jan; 77(1):113-20. PubMed ID: 8630916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
    Tan RYC; Ong WS; Lee KH; Park S; Iqbal J; Park YH; Lee JE; Yu JH; Lin CH; Lu YS; Ono M; Ueno T; Naito Y; Onishi T; Lim GH; Tan SM; Lee HB; Koh J; Han W; Im SA; Tan VKM; Phyu N; Wong FY; Tan PH; Yap YS
    J Natl Compr Canc Netw; 2024 May; 22(2D):. PubMed ID: 38744306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    Chen Z; Yang J; Li S; Lv M; Shen Y; Wang B; Li P; Yi M; Zhao X; Zhang L; Wang L; Yang J
    PLoS One; 2017; 12(9):e0182397. PubMed ID: 28863134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology.
    Blohmer M; Zhu L; Atkinson JM; Beriwal S; Rodríguez-López JL; Rosenzweig M; Brufsky AM; Tseng G; Lucas PC; Lee AV; Oesterreich S; Jankowitz RC
    Breast Cancer Res; 2020 Jun; 22(1):70. PubMed ID: 32586354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic profiles and survival differences between infiltrating ductal carcinoma and infiltrating lobular carcinoma in invasive breast cancer.
    Cavaller L; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102740. PubMed ID: 38311000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.
    Lobbezoo D; Truin W; Voogd A; Roumen R; Vreugdenhil G; Dercksen MW; van den Berkmortel F; Smilde T; van de Wouw A; van Kampen R; van Riel J; Peters N; Peer P; Tjan-Heijnen VC
    Oncotarget; 2016 May; 7(20):29412-9. PubMed ID: 27121067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
    Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base.
    Singletary SE; Patel-Parekh L; Bland KI
    Ann Surg; 2005 Aug; 242(2):281-9. PubMed ID: 16041220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
    Nakagawa S; Miyashita M; Maeda I; Goda A; Tada H; Amari M; Kojima Y; Tsugawa K; Ohi Y; Sagara Y; Sato M; Ebata A; Harada-Shoji N; Suzuki T; Nakanishi M; Ohta T; Ishida T
    Breast Cancer Res Treat; 2024 Apr; 204(3):453-463. PubMed ID: 38180699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast-Long-Term Prognostic Significance.
    Narbe U; Bendahl PO; Aaltonen K; Fernö M; Forsare C; Jørgensen CLT; Larsson AM; Rydén L
    Cells; 2020 Jul; 9(7):. PubMed ID: 32709042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment.
    Onkar S; Cui J; Zou J; Cardello C; Cillo AR; Uddin MR; Sagan A; Joy M; Osmanbeyoglu HU; Pogue-Geile KL; McAuliffe PF; Lucas PC; Tseng GC; Lee AV; Bruno TC; Oesterreich S; Vignali DAA
    Nat Cancer; 2023 Apr; 4(4):516-534. PubMed ID: 36927792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.
    Corso G; Fusco N; Guerini-Rocco E; Leonardi MC; Criscitiello C; Zagami P; Nicolò E; Mazzarol G; La Vecchia C; Pesapane F; Zanzottera C; Tarantino P; Petitto S; Bianchi B; Massari G; Boato A; Sibilio A; Polizzi A; Curigliano G; De Scalzi AM; Lauria F; Bonanni B; Marabelli M; Rotili A; Nicosia L; Albini A; Calvello M; Mukhtar RA; Robson ME; Sacchini V; Rennert G; Galimberti V; Veronesi P; Magnoni F
    Semin Oncol; 2024; 51(3-4):106-122. PubMed ID: 38897820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease events within 5 years after a diagnosis of breast cancer.
    Mery B; Fouilloux A; Rowinski E; Catella-Chatron J; Guichard JB; Da Costa A; Tinquaut F; Magné N; Bertoletti L
    BMC Cancer; 2020 Apr; 20(1):337. PubMed ID: 32398106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence in lobular carcinoma of the breast: A 14-year review.
    Burns N; Bourke A
    J Med Imaging Radiat Oncol; 2024 May; ():. PubMed ID: 38804125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1.
    Sflomos G; Battista L; Aouad P; De Martino F; Scabia V; Stravodimou A; Ayyanan A; Ifticene-Treboux A; ; Bucher P; Fiche M; Ambrosini G; Brisken C
    EMBO Mol Med; 2021 Mar; 13(3):e13180. PubMed ID: 33616307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Characterization of the immunologic and molecular landscape in a unique presentation of invasive lobular carcinoma with concurrent uterine carcinosarcoma treated with immunotherapy.
    Riedinger CJ; Eisele CD; Esnakula A; Stover DG; Freud AG; Cosgrove CM
    Front Immunol; 2024; 15():1422342. PubMed ID: 39076998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions.
    Sflomos G; Schipper K; Koorman T; Fitzpatrick A; Oesterreich S; Lee AV; Jonkers J; Brunton VG; Christgen M; Isacke C; Derksen PWB; Brisken C
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer in Younger and Older Women: A Comparison of Clinicopathological Traits.
    Jahan S; Rahman MM; Biswas SK; Hossain ATM; Saha B; Haque SMA
    Mymensingh Med J; 2024 Apr; 33(2):433-439. PubMed ID: 38557522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India--a cross-sectional study.
    Saxena S; Rekhi B; Bansal A; Bagga A; Chintamani ; Murthy NS
    World J Surg Oncol; 2005 Oct; 3():67. PubMed ID: 16236180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.